Adagene Inc.

ADAGReported to SECin USCIK 0001818838Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 9. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 9
Form 4 lines at Adagene Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Tam Man KinChief Financial OfficerOpen-market buy$6,0002,000 sharesSep 25, 2026Tam Man KinChief Financial Officer$6,000Buy · Sep 25Open-market buy2,000Sep 25, 2026
Luo PeterChief Executive OfficerOpen-market buy$63,98020,290 sharesSep 17, 2026Luo PeterChief Executive Officer$63,980Buy · Sep 17Open-market buy20,290Sep 17, 2026
DO CUONG V—Open-market buy$7,5002,000 sharesAug 18, 2026DO CUONG V$7,500Buy · Aug 18Open-market buy2,000Aug 18, 2026
Zhu Li—Awardnothing paid20,000 sharesAug 17, 2026Zhu Linothing paidAward · Aug 17Award20,000Aug 17, 2026
Cheung Andy Yiu Leung—Awardnothing paid20,000 sharesAug 17, 2026Cheung Andy Yiu Leungnothing paidAward · Aug 17Award20,000Aug 17, 2026